Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
14 458 158 8,632 8,804
AB
9 1,046 185 20,082 20,311
SK
0 495 129 16,186 16,343
MB
4 901 155 25,118 25,283
ON
81 365 80 21,111 21,459
QC
86 115 26 13,653 13,793
Atlantic
0 14 9 4,614 4,658
North60
10 326 56 19,406 19,499
 

COVID-19 prevention drug coming for immunocompromised New Brunswickers – CBC

Evusheld was approved by Health Canada for people aged 12 or older

May 05, 2022

A drug that could prevent immunocompromised people from developing COVID-19 will soon be available in New Brunswick.

Evusheld was approved last month by Health Canada for people aged 12 or older who are immunocompromised and unlikely to mount an adequate immune response to COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.

The antibody treatment, developed by AstraZeneca, is administered through two injections before people become infected or have had a known recent exposure to the virus.

“The introduction of this treatment is good news for some specific situations,” Department of Health spokesperson Bruce Macfarlane said in an emailed statement.

“This medication may be part of a treatment plan prescribed by physicians after a clinical assessment to a limited number of individuals.”

Read more: https://www.cbc.ca/news/canada/new-brunswick/covid-19-prevention-drug-evusheld-new-brunswick-astrazeneca-1.6441677

NationTalk Partners & Sponsors Learn More